Rare diseases
Investigational molecules
Locations
De Limes 7, 2342 DH, The Netherlands
Videja B.V. focuses on severe combined immunodeficiency linked to a genetic defect in RAG1, with research centered on restoring immune function in affected patients.
The sponsor’s clinical activity is directed toward conditions in which profound defects in adaptive immunity create early and life-threatening vulnerability to infection.
Videja B.V. runs clinical trials in conditions such as Autologous haematopoietic stem cell transplant, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
